i
Suppl.ementary table and Suppl.ementary figure for: Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — U.S. March 2020–August 2021
-
01/14/2022
-
Source: MMWR Morb Mortal Wkly Rep 2022;71:96–102.
Details:
-
Corporate Authors:
-
Description:Suppl.ementary table and Suppl.ementary figure for: Wiltz JL, Feehan AK, Molinari NM, et al. Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — U.S. March 2020–August 2021. MMWR Morb Mortal Wkly Rep 2022;71:96–102.
-
Content Notes:Suppl.EMENTARY FIGURE. Monthly* percentage of COVID-19 inpatients (n=120,204) receiving treatments dexamethasone or remdesivir by race† and ethnicity§ — 41 health care systems in the National Patient-Centered Clinical Research Network — U.S. March 2020–August 2021 -- Suppl.EMENTARY TABLE. Comparison of sociodemographic characteristics in COVID-19 patients aged ≥20 years — 41 National Patient-Centered Clinical Research Network Partner health systems with CDC case reports*, March 2020–August 2021
-
Subjects:
-
Source:
-
Place as Subject:
-
Pages in Document:gau
-
Volume:71
-
Issue:3
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: